Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Naloxone hydrochloride
(D11620)		[1] Naloxone[3] Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
2Naloxone hydrochloride dihydrate
(D11620)		[1] Naloxone[3] Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
3Oxycodone naloxone prolonged release tablets
(D11620)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
4Oxycodone/naloxone prolonged release T
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
5Oxycodone/naloxone prolonged release tablets
(D11620)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
6Oxycodone/naloxone prolonged release tablets 10 MG /5 MG
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
7Oxycodone/naloxone prolonged release tablets 10/5 MG
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
8Oxycodone/naloxone prolonged release tablets 20 MG /10 MG
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
9Oxycodone/naloxone prolonged release tablets 20/10 MG
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
10Oxycodone/naloxone prolonged release tablets 5 MG /2.5 MG
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
11Oxycodone/naloxone prolonged release tablets 5/2.5 MG
(D11620)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate (D11620) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬